Barriers to insulin initiation and intensification and how to overcome them

International Journal of Clinical Practice

Volumn 63, Issue SUPPL. 164, 2009, Pages 6-10

  Kunt, T ^a,b   Snoek, F J ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Private Diabetes Clinic   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CLINICAL PRACTICE; FEAR; GLYCEMIC CONTROL; HEALTH BELIEF; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PATIENT ATTITUDE; PATIENT CARE; PERCEPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; TRAINING; WEIGHT GAIN;

EID: 73349087520     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02176.x     Document Type: Review

References (15)

1. Ford ES, Li C, Little RR et al. Trends in A1C concentrations among US adults with diagnosed diabetes from 1999 to 2004. Diabetes Care 2008 31 : 102 104.
2. Millett C, Netuveli G, Saxena S et al. Impact of pay for performance on ethnic disparities in intermediate outcomes for diabetes: a longitudinal study. Diabetes Care 2009 32 : 404 409.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 853.
4. Polonsky WH, Fisher L, Guzman S et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005 28 : 2543 2545.
5. Peyrot M, Rubin RR, Lauritzen T et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005 28 : 2673 2679. (Pubitemid 43951158)
6. Dunning T. Exploring the world mythology of diabetes. Diabetes Voice 2004 49 : 30 3.
7. Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ 2006 32 (1 Suppl. 9S 18S.
8. Vijan S, Hayward RA, Ronis DL et al. Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens. J Gen Intern Med 2005 20 : 479 482.
9. Snoek FJ, Skovlund SE, Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes 2007 5 : 69. doi
10. Elgrably F, Costagliola D, Chwalow AJ et al. Initiation of insulin treatment after 70 years of age: patient status 2 years later. Diabet Med 1991 8 : 773 777.
11. Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJM 2000 93 : 369 374.
12. International Diabetes Federation. Global Guideline for Type 2 Diabetes, 2005. http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf (accessed April 2009).
13. Küstner E. How to convince people with type 2 diabetes to start with insulin? Treatment options for patients with psychological insulin resistance. MMW Fortschr Med 2008 150 : 49 52.
14. Sreenan S, Virkamäki A, Zhang K et al. Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study. Int J Clin Pract 2008 62 : 1971 1980.
15. Meneghini L, Koenen C, Weng W et al. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes - results of the randomized, controlled PREDICTIVE 303 study. Diabetes Obes Metab 2007 9 : 902 913.